[go: up one dir, main page]

Milstone, 1942 - Google Patents

Purification of thrombin

Milstone, 1942

View PDF
Document ID
9933147738094945665
Author
Milstone H
Publication year
Publication venue
The Journal of General Physiology

External Links

Snippet

1. Under certain conditions crude prothrombin changes to thrombin without the addition of extraneous activators and in the absence of ionic calcium. 2. Thrombin is soluble in 0.45 saturated ammonium sulfate, whereas crude prothrombin is not. 3. Partially purified thrombin …
Continue reading at pmc.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood

Similar Documents

Publication Publication Date Title
Milstone Purification of thrombin
US4027013A (en) Clottable fibrinogen free factor VIII and albumin product and process
Morrison et al. Preparation and properties of serum and plasma proteins. XVIII. The separation of purified fibrinogen from fraction I of human plasma.
Oncley et al. The separation of the antibodies, isoagglutinins, prothrombin, plasminogen and β1-lipoprotein into subfractions of human plasma
Lorand et al. The action of thrombin on fibrinogen
US4203891A (en) Method of collecting anti-hemophilic factor VIII from blood and blood plasma using heparin or sodium heparin
Smith et al. Prothrombin deficiency and the bleeding tendency in liver injury (chloroform intoxication)
US3931399A (en) Process for isolating a fibrin-stabilizing factor
US3682881A (en) Fractionation of plasma using glycine and polyethylene glycol
Miles et al. The properties of antigenic preparations from Brucella melitensis: I. Chemical and physical properties of bacterial fractions
Wake Studies of casein V. The action of rennin on casein
US4087415A (en) Antithrombin III
Mellanby Prothrombase—Its preparation and properties
DE2734427A1 (en) METHOD OF OBTAINING THROMBINAL ENZYMES FROM SNAKE POISON
Surgenor et al. A system for the separation of the protein components of human plasma. II. The components of the clotting process.
IE42769B1 (en) Soluble collagen composition
Howe The influenza virus receptor and blood group antigens of human erythrocyte stroma
Owren A new, previously unknown clotting factor
Munro Properties of an anticoagulant found in the blood of a hemophiliac
US2847350A (en) Preparation of highly active thromboplastin
Ferguson An intermediary calcium complex in blood coagulation
US2543215A (en) Process of preparing antibody-rich globulin fractions
Harder et al. In vitro and in vivo induction of cryofibrinogen and “paracoagulation” by reptilase
US2624691A (en) Fibrinolysin derived from blood and methods of obtaining the same
GB1581472A (en) Compounds of the plasminogen type processes for their production and pharmaceutical compositions containing them